lobbying_filings_raw: 94a5e9c2-b9bb-40c5-b494-e4febd5b6d9c
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94a5e9c2-b9bb-40c5-b494-e4febd5b6d9c | Q1 | 8511 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 112734 | TUBEROUS SCLEROSIS ALLIANCE | 2016 | first_quarter | 2016-04-13T16:21:28.037000-04:00 | 30000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/94a5e9c2-b9bb-40c5-b494-e4febd5b6d9c/", "filing_uuid": "94a5e9c2-b9bb-40c5-b494-e4febd5b6d9c", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2016, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/94a5e9c2-b9bb-40c5-b494-e4febd5b6d9c/print/", "filing_document_content_type": "text/html", "income": "30000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Katina Pierce", "dt_posted": "2016-04-13T16:21:28.037000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "600 Maryland Avenue, SW", "registrant_address_2": "SUITE 835W", "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20024", "registrant": {"id": 8511, "url": "https://lda.senate.gov/api/v1/registrants/8511/", "house_registrant_id": 31321, "name": "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", "description": "Consultant firm", "address_1": "600 Maryland Avenue SW", "address_2": "Suite 220E", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20024", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "KATINA PIERCE", "contact_telephone": "+1 202-484-1100", "dt_updated": "2026-01-09T10:20:33.802241-05:00"}, "client": {"id": 112734, "url": "https://lda.senate.gov/api/v1/clients/112734/", "client_id": 378, "name": "TUBEROUS SCLEROSIS ALLIANCE", "general_description": null, "client_government_entity": false, "client_self_select": null, "state": "MD", "state_display": "Maryland", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-07-30"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "FY 2017, Labor-HHS-Education Appropriations bill, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention.\nFY 2017, Defense Appropriations, FY 2017 defense health programs, Tuberous Sclerosis Complex Research Program.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 32743, "prefix": null, "prefix_display": null, "first_name": "MARK", "nickname": null, "middle_name": null, "last_name": "VIETH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 1960, "prefix": null, "prefix_display": null, "first_name": "DOMENIC", "nickname": null, "middle_name": null, "last_name": "RUSCIO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 139, "name": "Natl Institutes of Health (NIH)"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "FY 2017, Labor-HHS-Education Appropriations bill, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention.\nFY 2017, Defense Appropriations, FY 2017 defense health programs, Tuberous Sclerosis Complex Research Program.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 32743, "prefix": null, "prefix_display": null, "first_name": "MARK", "nickname": null, "middle_name": null, "last_name": "VIETH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 1960, "prefix": null, "prefix_display": null, "first_name": "DOMENIC", "nickname": null, "middle_name": null, "last_name": "RUSCIO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 139, "name": "Natl Institutes of Health (NIH)"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "FY 2017, Labor-HHS-Education Appropriations bill, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention.\nFY 2017, Defense Appropriations, FY 2017 defense health programs, Tuberous Sclerosis Complex Research Program.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 32743, "prefix": null, "prefix_display": null, "first_name": "MARK", "nickname": null, "middle_name": null, "last_name": "VIETH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 1960, "prefix": null, "prefix_display": null, "first_name": "DOMENIC", "nickname": null, "middle_name": null, "last_name": "RUSCIO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 139, "name": "Natl Institutes of Health (NIH)"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |